PARKLAND, Fla., Aug. 14, 2019 /PRNewswire/ -- Parkland Cares has awarded $239,000 to six mental health-counseling centers and now the nonprofit, which focuse

VANCOUVER and HOUSTON, Aug. 14, 2019 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financial results for the fiscal third quarter ended

• Second Quarter Adjusted Total Revenue - $19.1 million •• Second Quarter Adjusted EBITDA - $5.7 million •• Second Quarter Gross Profit - $9.6 million •

GERMANTOWN, Md., Aug. 14, 2019 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell and small molecule technologies, reported its financial results for the second quarter ended June 30, 2019.RECENT HIGHLIGHTS & ACCOM

MONMOUTH JUNCTION, N.J., Aug. 14, 2019 /PRNewswire/ -- Tris Pharma, Inc. ("Tris"), a specialty pharmaceutical company with a robust portfolio of approved New Drug Applications and a late-stage pipeline of innovative product candidates for the treatment of Attention-Deficit Hyperactivity Disorder and related disorders, is announcing that its Chief Medical Officer,

KELOWNA, BC, Aug. 14, 2019 /PRNewswire/ - Valens GroWorks Corp. (TSXV: VGW) (OTC: VGWCF) (the "Company" or "Valens"), a vertically integrated provider of industry leading extraction products and services; including a diverse suite of extraction methodologies, next generation cannabinoid delivery formats and an ISO 17025 accredited analytical lab

FDA Accepts New Drug Application for BrinavessTM; PDUFA Date Set for December 24, 2019Recently Strengthened Balance Sheet Extends Cash Runway Into Mid-2020Management to Host Conference Call and Webcast Today, August 14, 2019 at 8

TOWSON, Md., Aug. 14, 2019 /PRNewswire/ -- Inc. Magazine today announced that Confidio, a technology-enabled pharmacy benefits advisory firm based in Towson, has been named to the coveted Inc. 5000 List of Fastest Growing U.S. Companies for 2019. Confidio scored a ranking of number 81 overall, number 10 within the healthcare sector, numbe

TARRYTOWN, N.Y., Aug. 14, 2019 /PRNewswire/ --Adding evinacumab reduced LDL cholesterol by 49% in patients with homozygous familial hypercholesterolemia, compared to lipid-lowering therapies alone Evinacumab was generally well-tolerated, and all evinacumab patients completed the six-month treatment periodRegeneron Pharmaceuticals, Inc.

IRVINE, Calif., Aug. 14, 2019 /PRNewswire/ -- AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today updated clinical data from its ongoing glioblastoma Phase 2 clinical trial, investigating AIVITA's platform immunotherapy targeting tumor-initiating cells. Blood plasma biomarker analyses have identified a robust